BNET Industries
- Private
Dow Jones Description
Guidant Corporation is doing business as Boston Scientific Corporation.
Contact Information
Peer Companies
NAICS Code Diagnostic Imaging Centers: 621512
Recent Events
-
This Company Is a Value Stock! Isn't It?
-
Mid-Market Merger Update
-
Obama health czar led companies in trouble
-
Boston Scientific names new chief: Tobin, who oversaw Guidant acquisition, will retire in July
News & Analysis
Filter by
benefit and guidant corp. - All News and Analysis
Guidant Reports Excellent 12-Month Results from SPIRIT FIRST Everolimus Eluting Coronary Stent Clinical Trial; Results Demonstrate Sustained Benefit of the XIENCE V Everolimus Eluting Coronary Stent System
INDIANAPOLIS, Ind., & DALLAS, Texas -- Guidant Corporation (NYSE:GDT) today announced 12-month adjudicated results from the company's SPIRIT FIRST clinical trial. SPIRIT FIRST is a prospective, randomized, single-blind trial evaluating Guidant's rapid-exchange XIENCETM V Everolimus Eluting Coronary Stent System versus an uncoated MULTI-LINK VISIONR Coronary Stent System control in de...
Guidant Sponsors Biological Pacemaker Research with Columbia and Stony Brook Universities; Collaboration Explores Advanced Applications for Gene Therapy to Benefit Heart Patients
INDIANAPOLIS & ST. PAUL, Minn. -- Guidant Corporation (NYSE:GDT) today announced a collaboration with Columbia University Medical Center and Stony Brook University to study a new gene therapy that may ultimately provide a better understanding of how genetically engineered cells can help pace the heart. This five-year, phased investment will...
Guidant's MULTI-LINK Stents Demonstrate Benefit to Heart Attack Patients; CADILLAC Trial Was Largest Interventional Trial Evaluating Heart Attack Patients
Business Editors and Health/Medical Writers
Guidant Announces Excellent Preliminary Results of Paclitaxel Eluting Stent Trial; DELIVER and ELUTES Data Continue to Support Benefit of Paclitaxel Eluting Stents
Business Editors/Health & Medical Writers
Guidant Initiates New International Paclitaxel Eluting Stent Trial; Largest Study to Date, DELIVER II Will Evaluate Clinical Benefit of ACHIEVE Stent in High-Risk Patients
Business Editors, Health & Medical Writers
Guidant Launches Advanced Stent System in Japan; New Technology Offering Provides Significant Benefit to Second Largest Coronary Stent Market in the World
Business Editors & Health/Medical Writers
Guidant's Heart Failure Trial Supports Benefits of the Combination of Cardiac Resynchronization and Defibrillation Therapies
Business & Health/Medical Editors
- 1
Industry Transcripts by Seeking Alpha
-
Medtronic Inc. F2Q10 (Qtr End 10/30/09) Earnings Call Transcript
on Nov 24, 2009about MDT
-
ZOLL Medical Corporation F4Q09 (Qtr End 27/09/09) Earnings Call Transcript
on Nov 11, 2009about ZOLL
-
RadNet, Inc. Q3 2009 Earnings Call Transcript
on Nov 09, 2009about RDNT
-
Cytori Therapeutics Q3 2009 Earnings Call Transcript
on Nov 09, 2009about CYTX
-
StoneMor Partners L.P. 3Q09 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 09, 2009about STON
IndustryTop Rated
- Why So Many Insured People Have Big Medical Debts 5 votes
- Healthcare Is Still Adding Jobs, Despite Recession 3 votes
- Hospital Chain's Turnaround Raises Health Spending 3 votes
- Healthcare Roundup: Medical Office Space in Demand, Blues Companies See Lower Income, Two Sides of Health Insurance, and More 3 votes
- More Insurance Competition Will Not Reduce Costs 2 votes


